US$ 23.04
glp-1 coverage medicare covers GLP-1s to treat diabetes and some other health conditions, including obstructive sleep apnea and cardiovascular disease, but not obesity Medicare Spending on Ozempic and
Description
AI and GLP-1s: Transforming Obesity Care Through Digital Innovation Apr 14, 2025 4 min read By Brian Conyer REVOLUTIONIZING CLINICAL TRIALS AND REAL-WORLD RESEARCH The convergence of artificial intelligence (AI) and GLP-1 receptor agonists (GLP1-RA) is reshaping obesity treatment, creating unprecedented opportunities for innovation in clinical research, healthcare delivery, and patient care

But only when approached in the right way

GLP-1RA, as a glucose reducing medication, can reduce the glycation process and the production of AGEs

Best For
